Cushing's syndrome, primary aldosteronism
Conditions
Interventions
Sponsors
West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: ? Age > 18 years; ? Patients who require surgical treatment for removal of functional adrenal tumors and have increased cortisol levels or aldosterone levels as assessed by a specialist; (iii) Those who have not received vitreous cavity injections of medications, laser photocoagulation therapy and other internal ocular surgeries, or history of ocular trauma; ? Using OCT, OCTA examination can more accurately present the retinal choroidal structure, and the image quality is greater than 6; ? Signed informed consent and willing to follow up according to the time specified in the trial.
Exclusion criteria
Exclusion criteria: ? High myopia over 6.00D or eye axis length >26.5mm; ? Combined with other fundus diseases except central plasma retinopathy (including high myopia, glaucoma, diabetic retinopathy, retinal arteriovenous occlusion, macular degeneration, etc.); ?History of treatment for ocular diseases (including history of ophthalmic surgery or laser treatment, etc.); (iv) Those who have significant turbidity of the refractive media, which affects the quality of OCTA images and the image quality is less than 6; and Those who have poor adherence to treatment and have difficulty in regular outpatient review and cooperation with treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| density of choroidal blood flow;density of choroidal blood flow; | — |
Secondary
| Measure | Time frame |
|---|---|
| intraocular pressure; | — |
Countries
China
Contacts
Public ContactMeixia Zhang
West China Hospital, Sichuan University
Outcome results
None listed